Reporte zur Charge FJ582 the numbe

Symptomtext

non- occlusive dvt right leg; pain; rash; skin eruption in right leg; pityriasis rosea; swelling and rash with skin eruption in right leg; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative. A 54-year-old male patient received BNT162b2 (BNT162B2), on 30Jun2021 as dose 1, single (Lot number: EW0185), on 22Jul2021 as dose 2, single (Lot number: EW0186) and on 14Jan2022 as dose 3 (booster), single (Lot number: FJ582) for covid-19 immunisation. The patient's relevant medical history included: "patient has htn" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "obesity" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing). Concomitant medication(s) included: TIZANIDINE; TRAMADOL; CLONAZEPAM; OLMESARTAN; FUROSEMIDE; AMITRIPTYLINE; PEPCID AC; TRIAMCINOLONE ACETONIDE; ABILIFY; HEMOCYTE PLUS; DISULFIRAM; XARELTO. The following information was reported: DEEP VEIN THROMBOSIS (medically significant), outcome "unknown", described as "non- occlusive dvt right leg"; PAIN (non-serious), outcome "unknown"; RASH (non-serious), outcome "unknown"; RASH (non-serious), outcome "unknown", described as "skin eruption in right leg"; PITYRIASIS ROSEA (non-serious), outcome "unknown"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "swelling and rash with skin eruption in right leg". The clinical course reported as Patient experienced pain, swelling and rash with skin eruption in right leg and diagnosed with non- occlusive dvt right leg and pityriasis rosea 20Feb2022. Optional information: patient has htn (Hypertension), diabetes, obesity, hyperlipidemia. Pfizer covid vaccine 1st dose 30jun21 (EW0185), 2nd dose 22Jul2021(EW0186), Booster 14Jan2022 (FJ582). Event took place after use of product. No follow-up attempts are possible. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the event Deep vein thrombosis and the suspect drug cannot be excluded. The case will be reassessed once new information is available.